112 related articles for article (PubMed ID: 3902081)
1. Synthesis of an insulin-like compound consisting of the A chain of insulin and a B chain corresponding to the B domain of human insulin-like growth factor I.
Joshi S; Burke GT; Katsoyannis PG
Biochemistry; 1985 Jul; 24(15):4208-14. PubMed ID: 3902081
[TBL] [Abstract][Full Text] [Related]
2. Determinants of growth-promoting activity reside in the A-domain of insulin-like growth factor I.
Chen ZZ; Schwartz GP; Zong L; Burke GT; Chanley JD; Katsoyannis PG
Biochemistry; 1988 Aug; 27(16):6105-11. PubMed ID: 3056519
[TBL] [Abstract][Full Text] [Related]
3. An insulin-like hybrid consisting of a modified A-domain of human insulin-like growth factor I and the B-chain of insulin.
Zong L; Burke GT; Katsoyannis PG
J Protein Chem; 1990 Aug; 9(4):389-95. PubMed ID: 2275749
[TBL] [Abstract][Full Text] [Related]
4. Structural features involved in the biological activity of insulin and the insulin-like growth factors: A27 insulin/BIGF-I.
Joshi S; Ogawa H; Burke GT; Tseng LY; Rechler MM; Katsoyannis PG
Biochem Biophys Res Commun; 1985 Dec; 133(2):423-9. PubMed ID: 3002339
[TBL] [Abstract][Full Text] [Related]
5. An insulin-like compound consisting of the B-chain of bovine insulin and an A-chain corresponding to a modified A- and the D-domains of human insulin-like growth factor I.
Joshi S; Burke GT; Katsoyannis PG
J Protein Chem; 1990 Apr; 9(2):235-46. PubMed ID: 2201313
[TBL] [Abstract][Full Text] [Related]
6. Insulin analogues with modifications in the beta-turn of the B-chain.
Wang SH; Hu SQ; Burke GT; Katsoyannis PG
J Protein Chem; 1991 Jun; 10(3):313-24. PubMed ID: 1910463
[TBL] [Abstract][Full Text] [Related]
7. Hybrid molecules containing the A-domain of insulin-like growth factor-I and the B-chain of insulin have increased mitogenic activity relative to insulin.
Tseng LY; Schwartz GP; Sheikh M; Chen ZZ; Joshi S; Wang JF; Nissley SP; Burke GT; Katsoyannis PG; Rechler MM
Biochem Biophys Res Commun; 1987 Dec; 149(2):672-9. PubMed ID: 2447882
[TBL] [Abstract][Full Text] [Related]
8. An insulin analogue possessing higher in vitro biological activity than receptor binding affinity. [21-Proline-B]insulin.
Schwartz GP; Burke GT; Chanley JD; Katsoyannis PG
Biochemistry; 1983 Sep; 22(19):4561-7. PubMed ID: 6354263
[TBL] [Abstract][Full Text] [Related]
9. Serum half-life and biological activity of mutants of human insulin-like growth factor I which do not bind to serum binding proteins.
Cascieri MA; Saperstein R; Hayes NS; Green BG; Chicchi GG; Applebaum J; Bayne ML
Endocrinology; 1988 Jul; 123(1):373-81. PubMed ID: 2454805
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of an insulin analogue embodying a strongly fluorescent moiety, [19-tryptophan-A]insulin.
Ohta N; Burke GT; Katsoyannis PG
J Protein Chem; 1988 Feb; 7(1):55-65. PubMed ID: 3076448
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and characterization of molecular hybrids of insulin and insulin-like growth factor I. The role of the A-chain extension peptide.
King GL; Kahn CR; Samuels B; Danho W; Bullesbach EE; Gattner HG
J Biol Chem; 1982 Sep; 257(18):10869-73. PubMed ID: 7050123
[No Abstract] [Full Text] [Related]
12. An insulin-like growth factor I/insulin hybrid exhibiting high potency for interaction with the type I insulin-like growth factor and insulin receptors of placental plasma membranes.
Cara JF; Mirmira RG; Nakagawa SH; Tager HS
J Biol Chem; 1990 Oct; 265(29):17820-5. PubMed ID: 2170397
[TBL] [Abstract][Full Text] [Related]
13. Effect of N-methylation of selected peptide bonds on the biological activity of insulin. [2-N-methylisoleucine-A]insulin and [3-N-methylvaline-A]insulin.
Ogawa H; Burke GT; Chanley JD; Katsoyannis PG
Int J Pept Protein Res; 1987 Oct; 30(4):460-73. PubMed ID: 3323092
[TBL] [Abstract][Full Text] [Related]
14. Photoaffinity labeling of insulin receptor with an insulin analogue selectively modified at the amino terminal of the B chain.
Yeung CW; Moule ML; Yip CC
Biochemistry; 1980 May; 19(10):2196-203. PubMed ID: 6990974
[No Abstract] [Full Text] [Related]
15. Insulin activates the appearance of insulin-like growth factor II receptors on the adipocyte cell surface.
Oka Y; Mottola C; Oppenheimer CL; Czech MP
Proc Natl Acad Sci U S A; 1984 Jul; 81(13):4028-32. PubMed ID: 6330732
[TBL] [Abstract][Full Text] [Related]
16. Nature of the B10 amino acid residue. Requirements for high biological activity of insulin.
Burke GT; Schwartz G; Katsoyannis PG
Int J Pept Protein Res; 1984 Apr; 23(4):394-401. PubMed ID: 6373642
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of IGF-I-stimulated glucose transport in human adipocytes. Demonstration of specific IGF-I receptors not involved in stimulation of glucose transport.
Sinha MK; Buchanan C; Leggett N; Martin L; Khazanie PG; Dimarchi R; Pories WJ; Caro JF
Diabetes; 1989 Oct; 38(10):1217-25. PubMed ID: 2551760
[TBL] [Abstract][Full Text] [Related]
18. Mitogenic activity and receptor reactivity of hybrid molecules containing portions of the insulin-like growth factor I (IGF-I), IGF-II, and insulin molecules.
De Vroede MA; Rechler MM; Nissley SP; Ogawa H; Joshi S; Burke GT; Katsoyannis PG
Diabetes; 1986 Mar; 35(3):355-61. PubMed ID: 3005095
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphorylation of the receptor for insulin-like growth factor II is inhibited in plasma membranes from insulin-treated rat adipocytes.
Corvera S; Yagaloff KA; Whitehead RE; Czech MP
Biochem J; 1988 Feb; 250(1):47-52. PubMed ID: 2965577
[TBL] [Abstract][Full Text] [Related]
20. High-potency hybrid compounds related to insulin and amphioxus insulin-like peptide.
Chu YC; Burke GT; Gammeltoft S; Chan SJ; Steiner DF; Katsoyannis PG
Biochemistry; 1994 Nov; 33(44):13087-92. PubMed ID: 7947713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
